Results 121 to 130 of about 5,467 (204)

Severe Thiopurine-Induced Myelosuppression in a Pediatric Acute Lymphoblastic Leukemia Patient With the NUDT15 *1/*6 Genotype: A Brief Report. [PDF]

open access: yesClin Transl Sci
Fry J   +10 more
europepmc   +1 more source

硫唑嘌呤治疗系统性红斑狼疮的不良反应与硫嘌呤甲基转移酶活性的关系

open access: yesZhongshan Daxue xuebao. Yixue kexue ban, 2011
【目的】探讨硫唑嘌呤(AZA)在系统性红斑狼疮(SLE)维持治疗中的不良反应(ARD)以及与硫嘌呤甲基转移酶(TPMT)活性的关系。【方法】分析AZA在250例SLE患者维持治疗中的ARD发生特点,并应用高效液相色谱法(HPLC) 测定这部分患者红细胞TPMT 活性,分析TPMT活性与AZA所致不良反应的关系。【结果】最常见的ARD是血液系统损害(21例,8.4%),其次为胃肠道反应(19例,7.6%),肝功能异常(8例,3.2%)、脱发(5例,2.0%),急性胰腺炎1例 ...
doaj  

Clinical experience in the treatment and prognosis of seven cases of Cronkhite-Canada syndrome. [PDF]

open access: yesMedicine (Baltimore)
Bae J   +6 more
europepmc   +1 more source

Population frequencies of thiopurine-related pharmacogenes in healthy individuals from Kosovo. [PDF]

open access: yesHum Genome Var
Pasha F   +6 more
europepmc   +1 more source

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2025 Update. [PDF]

open access: yesClin Pharmacol Ther
Maillard M   +18 more
europepmc   +1 more source

Association between genetically predicted expression of TPMT and azathioprine adverse events. [PDF]

open access: yesBMC Pharmacol Toxicol
Steitz A   +14 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy